326 related articles for article (PubMed ID: 31415975)
21. Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.
Velychko S; Adachi K; Kim KP; Hou Y; MacCarthy CM; Wu G; Schöler HR
Cell Stem Cell; 2019 Dec; 25(6):737-753.e4. PubMed ID: 31708402
[TBL] [Abstract][Full Text] [Related]
22. Reprogramming bladder cancer cells for studying cancer initiation and progression.
Iskender B; Izgi K; Canatan H
Tumour Biol; 2016 Oct; 37(10):13237-13245. PubMed ID: 27456363
[TBL] [Abstract][Full Text] [Related]
23. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
[TBL] [Abstract][Full Text] [Related]
24. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
[TBL] [Abstract][Full Text] [Related]
25. Generation and characterization of a human iPSC line (UAMi005-A) from a patient with nonketotic hyperglycinemia due to mutations in the GLDC gene.
Arribas-Carreira L; Bravo-Alonso I; López-Márquez A; Alonso-Barroso E; Briso-Montiano Á; Arroyo I; Ugarte M; Pérez B; Pérez-Cerdá C; Rodríguez-Pombo P; Richard E
Stem Cell Res; 2019 Aug; 39():101503. PubMed ID: 31349202
[TBL] [Abstract][Full Text] [Related]
26. Generation of three human induced pluripotent stem cell (iPSC) lines from three patients with Dravet syndrome carrying distinct SCN1A gene mutations.
Schuster J; Fatima A; Sobol M; Norradin FH; Laan L; Dahl N
Stem Cell Res; 2019 Aug; 39():101523. PubMed ID: 31400703
[TBL] [Abstract][Full Text] [Related]
27. Generation of two human iPSC lines (MDCUi001-A and MDCUi001-B) from dermal fibroblasts of a Thai patient with X-linked osteogenesis imperfecta using integration-free Sendai virus.
Tongkobpetch S; Rungsiwiwut R; Pruksananonda K; Suphapeetiporn K; Shotelersuk V
Stem Cell Res; 2019 Aug; 39():101493. PubMed ID: 31326747
[TBL] [Abstract][Full Text] [Related]
28. Efficient generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells.
Gao Y; Cheng Y; Wen J; Xiao D; Xu J; Cai C; Hu J
Stem Cell Res; 2023 Jun; 69():103088. PubMed ID: 37099933
[TBL] [Abstract][Full Text] [Related]
29. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency.
Yamakawa T; Sato Y; Matsumura Y; Kobayashi Y; Kawamura Y; Goshima N; Yamanaka S; Okita K
Stem Cells; 2016 Nov; 34(11):2661-2669. PubMed ID: 27335261
[TBL] [Abstract][Full Text] [Related]
30. Generation of human iPS cell line IBCHi001-A from dentatorubral-pallidoluysian atrophy patient's fibroblasts.
Kozlowska E; Ciolak A; Olejniczak M; Fiszer A
Stem Cell Res; 2019 Aug; 39():101512. PubMed ID: 31374462
[TBL] [Abstract][Full Text] [Related]
31. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
33. Efficient induction of pluripotent stem cells from menstrual blood.
Li Y; Li X; Zhao H; Feng R; Zhang X; Tai D; An G; Wen J; Tan J
Stem Cells Dev; 2013 Apr; 22(7):1147-58. PubMed ID: 23151296
[TBL] [Abstract][Full Text] [Related]
34. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma.
Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H
Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001
[TBL] [Abstract][Full Text] [Related]
35. Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults.
Vlahos K; Sourris K; Mayberry R; McDonald P; Bruveris FF; Schiesser JV; Bozaoglu K; Lockhart PJ; Stanley EG; Elefanty AG
Stem Cell Res; 2019 Jan; 34():101380. PubMed ID: 30605840
[TBL] [Abstract][Full Text] [Related]
36. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
37. Reprogramming Human Fibroblasts to Induced Pluripotent Stem Cells Using the GFP-Marked Lentiviral Vectors in the Chemically Defined Medium.
Shao Z; Cevallos RR; Hu K
Methods Mol Biol; 2021; 2239():101-116. PubMed ID: 33226615
[TBL] [Abstract][Full Text] [Related]
38. Integration-free induced pluripotent stem cells derived from a patient with autosomal recessive Alport syndrome (ARAS).
Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
Stem Cell Res; 2017 Dec; 25():1-5. PubMed ID: 29246570
[TBL] [Abstract][Full Text] [Related]
39. Fine-tuning of iPSC derivation by an inducible reprogramming system at the protein level.
Sui D; Sun Z; Xu C; Wu Y; Capecchi MR; Wu S; Li N
Stem Cell Reports; 2014 May; 2(5):721-33. PubMed ID: 24936457
[TBL] [Abstract][Full Text] [Related]
40. Induced pluripotent stem cell generation from bovine somatic cells indicates unmet needs for pluripotency sustenance.
Pillai VV; Kei TG; Reddy SE; Das M; Abratte C; Cheong SH; Selvaraj V
Anim Sci J; 2019 Sep; 90(9):1149-1160. PubMed ID: 31322312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]